NASDAQ · SINTHealthcareSurgical Instruments

SiNtx Technologies financials

$2.03+2.01%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
FY18
Dec 31
Revenue$1.0M$2.9M$2.6M$1.6M$606.0K$594.0K$689.0K$95.0K
Gross profit$461.0K$2.1M$1.8M$1.3M$157.0K$119.0K$138.0K$39.0K
Gross margin45.3%71.9%70.2%83.0%25.9%20.0%20.0%41.1%
Operating income-$10.7M-$14.0M-$13.4M-$11.3M-$10.6M-$8.5M-$6.6M-$13.1M
Net income-$17.1M-$11.0M-$8.3M-$16.5M-$9.3M-$16.6M-$7.5M-$22.6M
Net margin−1678.1%−381.8%−315.4%−1056.3%−1536.1%−2793.6%−1088.5%−23738.9%
Diluted EPS$-6.16$-15.19$-624.47$-12162.00$-7982.00$-21600.00$-113800.00$-1534600.00
EBITDA-$10.4M-$13.2M-$12.4M-$10.4M-$10.4M-$8.4M-$6.5M-$6.8M
Operating cash flow-$8.6M-$8.6M-$14.1M-$10.3M-$10.1M-$9.1M-$6.4M-$9.3M
Free cash flow-$8.8M-$9.3M-$14.6M-$11.7M-$13.9M-$9.5M-$6.6M-$9.4M
Diluted shares2.8M0.7M0.0M0.0M0.0M0.0M0.0M0.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$4.1M$3.6M$3.3M$6.2M$14.3M$25.4M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$7.0K$32.0K$46.0K$528.0K$509.0K$396.0K
Total assets$9.5M$9.4M$15.4M$15.8M$21.8M$30.4M
Total liabilities$6.6M$5.5M$6.6M$10.1M$4.6M$4.6M
Shareholders' equity$2.9M$3.9M$8.8M$5.7M$17.2M$25.8M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology